On Monday, Cogent Biosciences Inc (NASDAQ: COGT) was 5.79% up from the session before settling in for the closing price of $7.08. A 52-week range for COGT has been $3.72 – $12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 10.00%. With a float of $94.03 million, this company’s outstanding shares have now reached $113.86 million.
The firm has a total of 205 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cogent Biosciences Inc stocks. The insider ownership of Cogent Biosciences Inc is 17.41%, while institutional ownership is 100.06%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 10.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.85% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
You can see what Cogent Biosciences Inc (COGT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.38, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.89 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 2.11 million was better than the volume posted last year of 1.47 million. As of the previous 9 days, the stock’s Stochastic %D was 83.80%. Additionally, its Average True Range was 0.49.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 58.63%, which indicates a significant decrease from 94.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 75.41% in the past 14 days, which was lower than the 84.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.23, while its 200-day Moving Average is $8.17. Now, the first resistance to watch is $7.69. This is followed by the second major resistance level at $7.89. The third major resistance level sits at $8.26. If the price goes on to break the first support level at $7.12, it is likely to go to the next support level at $6.75. Now, if the price goes above the second support level, the third support stands at $6.55.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are 113,856K outstanding shares of the company, which has a market capitalization of 852.78 million. As of now, sales total 0 K while income totals -255,860 K. Its latest quarter income was 0 K while its last quarter net income were -71,990 K.
